The Radiation Oncology Registry and Biosample Repository
Part of paid clinical trials in Moorestown, New Jersey.
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study ID
- NCT01577251
- Status
- Recruiting
Conditions
- Neoplasia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.
Key Dates
- Start date
- Jun 30, 2008
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 8,000 participants (estimated)
Primary Outcome Measure
Health Assessments [ Time Frame: 10 years ]
Central Contacts
- Project Manager
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Virtua Samson Cancer Center | Moorestown | New Jersey | 08057 | Catherine Kim, MD (PRINCIPAL_INVESTIGATOR) |
| Virtua Health & Wellness Center | Voorhees Township | New Jersey | 08043 | Catherine Kim, MD (PRINCIPAL_INVESTIGATOR) |
| Lancaster General Hospital | Lancaster | Pennsylvania | 17604 | Pamela Boimel, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Project Manager Jay Dorsey, MD, PhD (PRINCIPAL_INVESTIGATOR) |